CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-11 | RALLIS CHRIS A Director | Option exercise · Stock Option 10b5-1 | −14,344 | $2.44 | $35K | 186,189 |
| 2026-05-01 | Raykov Rosty Director | Option exercise 10b5-1 | +15,598 | $2.45 | $38K | 132,232 |
| 2026-05-01 | Raykov Rosty Director | Sale 10b5-1 | −10,781 | $6.47 | $70K | 121,451 |
| 2026-05-01 | Raykov Rosty Director | Option exercise · Stock Options 10b5-1 | −15,598 | $2.45 | $38K | 1,571,792 |
| 2026-04-30 | Cioffi Christiana Marie Chief Strategy Officer | Option exercise | +155 | 24,020 | ||
| 2026-04-30 | Sayad Pierre Sargis Chief Medical Officer | Option exercise | +168 | 20,847 | ||
| 2026-04-30 | Evans Terry L Chief Commercial Officer | Option exercise | +168 | 20,847 | ||
| 2026-04-30 | Hackman Jeffrey S. Chief Executive Officer | Option exercise | +1,159 | 61,666 | ||
| 2026-04-30 | Raykov Rosty Director | Option exercise 10b5-1 | +2,778 | 116,634 | ||
| 2026-04-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +1,703 | 287,566 | ||
| 2026-04-01 | Raykov Rosty Director | Option exercise 10b5-1 | +15,598 | $2.45 | $38K | 124,802 |
| 2026-04-01 | Raykov Rosty Director | Sale 10b5-1 | −10,946 | $6.31 | $69K | 113,856 |
| 2026-04-01 | Raykov Rosty Director | Option exercise · Stock Options 10b5-1 | −15,598 | $2.45 | $38K | 1,587,390 |
| 2026-03-31 | Cioffi Christiana Marie Chief Strategy Officer | Option exercise | +17,106 | 21,806 | ||
| 2026-03-31 | Cioffi Christiana Marie Chief Strategy Officer | Option exercise | +158 | 21,964 | ||
| 2026-03-31 | Cioffi Christiana Marie Chief Strategy Officer | Grant or award · Stock Options | +120,000 | $5.77 | $692K | 265,300 |
| 2026-03-31 | Sayad Pierre Sargis Chief Medical Officer | Option exercise | +18,456 | 18,456 | ||
| 2026-03-31 | Sayad Pierre Sargis Chief Medical Officer | Option exercise | +171 | 18,627 | ||
| 2026-03-31 | Sayad Pierre Sargis Chief Medical Officer | Grant or award · Stock Options | +120,000 | $5.77 | $692K | 270,000 |
| 2026-03-31 | Evans Terry L Chief Commercial Officer | Option exercise | +18,456 | 18,456 |
Page 4 of 8 · 159 trades